# Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)

> **NCT06472310** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 5000 (estimated)

## Conditions studied

- Severe Asthma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06472310
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-06
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06472310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06472310, "Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06472310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*